We move beyond the superficial stop dates to explore why these drugs cause ketosis, how new endocrine pathways (like the AVP axis) are reshaping our risk models, and when the benefits of continuation might outweigh the risks of withdrawal
[PUBMED Abstract] Veronesi U, Cascinelli N, Adamus J, et al.: Thin stage I primary cutaneous malignant melanoma
Now, they are also approved to help people who struggle to lose weight
The Downstream Benefits of Weight Loss One big reason that GLP-1s have positive effects on a whole host of health conditions is that obesity is a major driver of what ails us
[9] [10] These medications work by mimicking incretin hormones, enhancing glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting satiety through central nervous system pathways